Clinical trial
Effects of Cocarnit on Macrophages Polarization in Type 2 Diabetic Patients
NCT03877523 is registered in ClinicalTrials.gov with Institute for Atherosclerosis Research, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effects of Cocarnit on Macrophages Polarization in Type 2 Diabetic Patients
- Lead sponsor
- Institute for Atherosclerosis Research, Russia
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 3, 2018
- Completion date
- December 20, 2018
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.